E-LIB Suche - Ergebnisse für: Jesaitis, Lynne

1

Safety, efficacy, and immunogenicity of elosulfase alfa in ..:

Hendriksz, Christian ; Santra, Saikat ; Jones, Simon A....
Molecular Genetics and Metabolism. 123 (2018) 2 - p. S61 , 2018

Link: https://doi.org/10.1016/..

2

Safety, immunogenicity, and clinical outcomes in patients w..:

Hendriksz, Christian ; Santra, Saikat ; Jones, Simon A....
Molecular Genetics and Metabolism. 123 (2018) 4 - p. 479-487 , 2018

Link: https://doi.org/10.1016/..

3

Detection of Antibodies That Neutralize the Cellular Uptake..

JoVE : Immunology and Infection

Cheung, Ruby ; deHart, Gregory W. ; Jesaitis, Lynne.. , 2018

Link: https://www.jove.com/t/5..

4

Antibodies that neutralize cellular uptake of elosulfase al..:

Melton, Andrew C. ; Soon Jr., Russell K. ; Tompkins, Troy...
Journal of Immunological Methods. 440 (2017) - p. 41-51 , 2017

Link: https://doi.org/10.1016/..

5

Long-term Immunogenicity of Elosulfase Alfa in the Treatmen..:

Long, Brian ; Tompkins, Troy ; Decker, Celeste...
Clinical Therapeutics. 39 (2017) 1 - p. 118-129.e3 , 2017

Link: https://doi.org/10.1016/..

6

Development of an electrochemiluminescent assay to measure ..:

Soon Jr, Russell K ; Tripp, Matt ; Chandriani, Sanjay...
Molecular Genetics and Metabolism. 120 (2017) 1-2 - p. S126 , 2017

Link: https://doi.org/10.1016/..

7

Immunogenicity of Elosulfase Alfa, an Enzyme Replacement Th..:

Schweighardt, Becky ; Tompkins, Troy ; Lau, Kelly...
Clinical Therapeutics. 37 (2015) 5 - p. 1012-1021.e6 , 2015

Link: https://doi.org/10.1016/..

8

Pharmacokinetic and Pharmacodynamic Evaluation of Elosulfas..:

Qi, Yulan ; Musson, Donald G. ; Schweighardt, Becky...
Clinical Pharmacokinetics. 53 (2014) 12 - p. 1137-1147 , 2014

Link: https://doi.org/10.1007/..

9

The extended auricle1 (eta1) Gene Is Essential for the Gene..:

Osmont, Karen S ; Jesaitis, Lynne A ; Freeling, Michael
Genetics. 165 (2003) 3 - p. 1507-1519 , 2003

Link: https://doi.org/10.1093/..

10

The Tight Junction Protein ZO-1 Establishes a Link between ..:

Fanning, Alan S. ; Jameson, Brian J. ; Jesaitis, Lynne A..
Journal of Biological Chemistry. 273 (1998) 45 - p. 29745-29753 , 1998

Link: https://doi.org/10.1074/..

11

The Tight Junction Protein ZO-2 Contains Three PDZ (PSD-95D..:

Beatch, Martin ; Jesaitis, Lynne A. ; Gallin, Warren J...
Journal of Biological Chemistry. 271 (1996) 42 - p. 25723-25726 , 1996

Link: https://doi.org/10.1074/..

12

Detection of Antibodies That Neutralize the Cellular Uptake..:

Cheung, Ruby ; deHart, Gregory W ; Jesaitis, Lynne..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235114/. , 2018

Link: http://www.ncbi.nlm.nih...

13

Safety, immunogenicity, and clinical outcomes in patients w..:

Hendriksz, Christian J ; Santra, Saikat ; Jones, Simon A...
Hendriksz, C.J., Santra, S., Jones, S., et al., 2018, 'Safety, immunogenicity, and clinical outcomes in patients with Morquio A syndrome participating in 2 sequential open-label studies of elosulfase alfa enzyme replacement therapy (MOR-002/MOR-100), representing 5 years of treatment', Molecular Genetics and Metabolism, vol. 123, no. 4, pp. 479-487.. , 2018

Link: http://hdl.handle.net/22..

14

Pharmacokinetic and Pharmacodynamic Evaluation of Elosulfas..:

Qi, Yulan ; Musson, Donald G ; Schweighardt, Becky...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC. , 2014

Link: http://www.ncbi.nlm.nih...

15

Anti-CS1 humanized monoclonal antibody HuLuc63 inhibits mye..:

Tai, Yu-Tzu ; Dillon, Myles ; Song, Weihua...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2515112. , 2008

Link: http://www.ncbi.nlm.nih...